Westwood Wealth Management Sells 760 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Westwood Wealth Management lessened its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 5.2% during the fourth quarter, Holdings Channel.com reports. The firm owned 13,740 shares of the financial services provider’s stock after selling 760 shares during the quarter. iShares Biotechnology ETF comprises about 0.7% of Westwood Wealth Management’s portfolio, making the stock its 19th largest holding. Westwood Wealth Management’s holdings in iShares Biotechnology ETF were worth $1,817,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also bought and sold shares of the company. HHM Wealth Advisors LLC increased its holdings in shares of iShares Biotechnology ETF by 200.0% during the fourth quarter. HHM Wealth Advisors LLC now owns 225 shares of the financial services provider’s stock valued at $30,000 after acquiring an additional 150 shares in the last quarter. VSM Wealth Advisory LLC purchased a new stake in iShares Biotechnology ETF during the 4th quarter valued at about $30,000. Bradley & Co. Private Wealth Management LLC bought a new stake in iShares Biotechnology ETF during the 4th quarter valued at about $32,000. Newbridge Financial Services Group Inc. purchased a new position in iShares Biotechnology ETF in the fourth quarter worth about $33,000. Finally, Hager Investment Management Services LLC bought a new position in shares of iShares Biotechnology ETF in the fourth quarter worth approximately $34,000. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Down 5.4 %

Shares of IBB opened at $117.16 on Friday. iShares Biotechnology ETF has a twelve month low of $117.02 and a twelve month high of $150.57. The company has a market capitalization of $5.27 billion, a P/E ratio of 24.21 and a beta of 0.82. The firm has a 50 day moving average of $134.95 and a 200 day moving average of $138.11.

iShares Biotechnology ETF Increases Dividend

The firm also recently announced a dividend, which was paid on Friday, March 21st. Shareholders of record on Tuesday, March 18th were issued a $0.1212 dividend. This is a positive change from iShares Biotechnology ETF’s previous dividend of $0.06. The ex-dividend date was Tuesday, March 18th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.